Category

News Brief

AavantiBio and Resilience Announce Strategic Collaboration for Gene Therapy Development and Manufacturing

UF startup and UF Innovate | The Hub resident AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and National Resilience, Inc. (Resilience), a company building the world’s most advanced biopharmaceutical manufacturing ecosystem and who recently acquired UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices, announced a strategic collaboration to support the development and manufacturing of AavantiBio’s pipeline of therapies, including its lead program in Friedreich’s Ataxia (FA).

COVID-19 Testing Method Gives Results Within 1 Second

Researchers from the University of Florida and Taiwan’s National Chiao Tung University have developed a rapid and sensitive testing method for COVID-19 biomarkers. Their findings were recently published in the Journal of Vacuum Science & Technology B.

Battling COVID-19 With Smart Wearables

Dr. Swarup Bhunia, director and the Semmoto Endowed Professor at University of Florida's Electric and Computer Engineering Department, and Dr. My T. Thai, associate director and UF's Research Foundation professor at the Computer and Information Science Engineering Department, share the different Covid-19 innovations coming out of the Warren B. Nelms Institute for the Connected World​.

How Nanotech Can Foil Counterfeiters

University of Florida researchers Dr. Roozbeh Tabrizian and Dr. Swarup Bhunia, professors in the Department of Electrical and Computer Engineering, have developed tiny mechanical ID tags that are unclonable, cheap, and invisible.

Yunnan Orbivirus Found in Florida for First Time

A new study by UF researchers, which published in Microbiology Resource Announcements, documents that Yunnan orbivirus is now in North America too, after it was identified in a farmed white-tailed deer in Florida.

Neobiosis Appoints Pascal Goldschmidt, M.D. as Chief Medical Officer

UF Innovate | Sid Martin Biotech resident Neobiosis, a clinical-stage contract development and manufacturing organization, managed by scientists and physicians and focused on the science of regenerative medicine, announced the appointment of Pascal Goldschmidt, M.D. as Chief Medical Officer.